REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Invest Pharmaceuticals Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Pharmaceutical and Medicine Manufacturing | Other Miscellaneous Manufacturing | Merchant Wholesalers, Durable Goods | Information | Motion Picture and Sound Recording Industries | Scientific Research and Development Services | All Other Professional, Scientific, and Technical Services | Office Administrative Services | Other Personal Care Services
Full name: Invest Pharmaceuticals Sp. z o.o. Profile Updated: August 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Novascon Pharmaceuticals Sp. z o.o. is a pharmaceutical company. The company develops and offers dietary supplements, including NEOSPAN Melatonin, claimed to improve sleep quality and alleviate jet lag. Novascon Pharmaceuticals Sp. z o.o. operates in the pharmaceutical industry.

Headquarters
Ul. Skierniewicka 10A
Warsaw; Mazowieckie; Postal Code: 01-230

Contact Details: Purchase the Invest Pharmaceuticals Sp. z o.o. report to view the information.

Website: http://www.novascon.pl

Basic Information
Total Employees:
Purchase the Invest Pharmaceuticals Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Invest Pharmaceuticals Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Invest Pharmaceuticals Sp. z o.o. report to view the information.
Incorporation Date:
May 28, 2007
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Inpharmax Investments Sp. z o.o.
45.05%
Inpharmax Investments Sp. z o.o. sp. j.
Company Performance
Financial values in the chart are available after Invest Pharmaceuticals Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-84.11%▼
Total operating revenue
-79.98%▼
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
94.67%▲
Total assets
-54.29%▼
Total equity
-3.08%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
11.67%▲
Return on Equity (ROE)
-54.88%▼
Debt to Equity Ratio
-2.56%▼
Quick Ratio
-0.11%▼
Cash Ratio
-0.01%▼

Similar companies

Mos Consulting Sp. z o.o.
 
Unilever Polska Sp. z o.o.
Doz S.A. Direct sp. k.
 
Bausch Health Poland Sp. z o.o.
PHUP Gniezno Szeszycki sp. k.
 
"Mgi Polska" Sp. z o.o.
"Istpol" Sp. z o.o.
 
Himtek Sp. z o.o.
"Hapis" Sp. z o.o.
 
Rezor Sp. z o.o.
Aqvitox Polska Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo